Publications directory

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm

The web Directory of Information Materials for People Affected by Cancer is regularly updated and currently has details of over 1,900 booklets, leaflets, books and audiovisual materials for people affected by cancer. Most have been published in the last five years but we have included some older ones that are still useful.

Results: 173

Cover image of 'Adult-T-cell-leukaemia/lymphoma (ATL). A guide for patients'

Adult-T-cell-leukaemia/lymphoma (ATL). A guide for patients (October 2019)

Leukaemia Care

This booklet describes T-cell-leukaemia/lymphoma (ATL) in adults, what causes it, who it affects, how it affects your body, what symptoms to expect and likely treatments. It also covers everyday life with ATL and how to talk to your haematologist and family and friends. Includes a glossary and details of further support. 

Cover image of 'Nodular lymphocyte-predominant Hodgkin lymphoma'

Nodular lymphocyte-predominant Hodgkin lymphoma (June 2018)

Lymphoma Action

Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is an uncommon type of Hodgkin lymphoma. This factsheet covers: What is NLPHL?; Who gets NLPHL and why?; Symptoms; Diagnosis and staging; Outlook; Treatment; Relapse; Transformation; Research.

Cover image of 'Causes of lymphoma'

Causes of lymphoma (April 2018)

Lymphoma Action

Information about the causes of lymphoma, including age and sex, family history, immune system problems, infections, previous cancers, non-cancerous factors and other possible causes.

Cover image of 'Lymphoma and the immune system'

Lymphoma and the immune system (April 2018)

Lymphoma Action

This factsheet describes how the immune system is affected by lymphoma and how the immune system may be used to treat lymphoma.

Cover image of 'Chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL)'

Chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL) (November 2018)

Lymphoma Action

Chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL) are different forms of the same disease. They are treated in the same way. CLL is used to refer to both forms in this booklet, except where there are important differences and SLL is discussed separately. This booklet explains what CLL is, how it is diagnosed and treated, and has tips on living with CLL. 

Cover image of 'Lymphoma in children'

Lymphoma in children (November 2018)

Lymphoma Action

This factsheet about lymphoma in children (0 to 14 years old) is primarily intended for parents and carers and covers: What is lymphoma?; Types of lymphoma in children; Symptoms; Tests; Outlook; Treatment; Side effects and late effects of treatment; Relapsed and refractory lymphoma; After treatment; Further information and support.

Cover image of 'Tom has lymphoma'

Tom has lymphoma (November 2018)

CLIC Sargent|Lymphoma Action

Tom is ten years old when he is diagnosed with lymphoma. This illustrated, colour storybook for parents to read with their children describes what happens when he has to go to the hospital for tests and treatment. The story follows Tom from when he first feels ill, through diagnosis and treatment, to recovery and return to normal life.

Cover image of 'Lymphoma with other health conditions'

Lymphoma with other health conditions (June 2018)

Lymphoma Action

Having another long-term health condition, being older (over 60) or being frail can affect what treatment you may receive for your lymphoma. This factsheet covers the following topics: Common long-term health conditions; Lymphoma treatment and health conditions; Lymphoma treatment and age; Adapting treatment; Support; Understanding your treatment options.

Cover image of 'Lymphoma drug development, approval and funding'

Lymphoma drug development, approval and funding (October 2018)

Lymphoma Action

This factsheet explains why drug development takes so long, why drugs are so expensive and how you can find out if a drug might be funded on the NHS. 

Cover image of 'Checkpoint inhibitors'

Checkpoint inhibitors (October 2018)

Lymphoma Action

Checkpoint inhibitors are a type of targeted drug used in the treatment of certain types of lymphoma. This factsheet explains what they are, who can have them and how they are given, the benefits and possible side effects.

Sorry, no publications found.
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm